These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 4771784)
1. [Penicillamine in the treatment of scleroderma]. Kobíková M; Stáva Z Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784 [No Abstract] [Full Text] [Related]
3. [Marked proteinuria in the course of penicillamine treatment of progressive systemic sclerosis]. Filipecki S; Dabrowska B; Szczepański A; Glyda J Pol Tyg Lek; 1971 Nov; 26(46):1780-1. PubMed ID: 5131995 [No Abstract] [Full Text] [Related]
4. [Experience using d-penicillamine in systemic scleroderma]. Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046 [No Abstract] [Full Text] [Related]
5. [Proteinuria in immunopathological diseases during long-term penicillamine therapy (author's transl)]. Hrncír Z; Tichý M Cas Lek Cesk; 1976 May; 115(18):549-51. PubMed ID: 1277236 [No Abstract] [Full Text] [Related]
6. [Therapeutic effect of d-penicillamine in scleroderma]. Bogdanikowa B; Rudy J; Bernacka K; Palka Z Pol Tyg Lek; 1973 Aug; 28(34):1317-20. PubMed ID: 4756401 [No Abstract] [Full Text] [Related]
7. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)]. Böni A; Pavelka K; Kludas M Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493 [No Abstract] [Full Text] [Related]
8. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment. Bluestone R; Grahame R; Holloway V; Holt PJ Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411 [No Abstract] [Full Text] [Related]
9. [D-penicillamine in the treatment of progressive systemic sclerosis]. Marques Neto JF; Manzato LC; Samara AM AMB Rev Assoc Med Bras; 1980 Jun; 26(6):191-3. PubMed ID: 6970374 [No Abstract] [Full Text] [Related]
10. [Treatment of generalized scleroderma with connective tissue inhibitors]. Asboe-Hansen G Ugeskr Laeger; 1976 May; 138(22):1325-9. PubMed ID: 1273949 [No Abstract] [Full Text] [Related]
11. [Penicillamine in the treatment of patients with systemic scleroderma]. Gandzha IM Vrach Delo; 1987 May; (5):66-7. PubMed ID: 3617690 [No Abstract] [Full Text] [Related]
12. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)]. Bröll H; Tausch G; Eberl R Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388 [TBL] [Abstract][Full Text] [Related]
13. [Effects and adverse effects of D-penicillamine]. Perings E; Junge U Med Klin; 1975 Aug; 70(31):1265-74. PubMed ID: 1107780 [No Abstract] [Full Text] [Related]
14. The toxicity of D-penicillamine in systemic sclerosis. Steen VD; Blair S; Medsger TA Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530 [TBL] [Abstract][Full Text] [Related]
15. [Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma]. Alekperov RT; Avdeev SN; Kotovskaia MA Ter Arkh; 2004; 76(3):74-6. PubMed ID: 15108466 [No Abstract] [Full Text] [Related]
16. [Treatment of chronic hepatitis with immunosuppressive agents and D-penicillamine]. Wallnöfer H; Hanusch M Wien Med Wochenschr; 1973 Jun; 123(25):402-8. PubMed ID: 4578041 [No Abstract] [Full Text] [Related]
17. [D-penicillamine therapy of chronic polyarthritis]. Günther R; Gabl F; Knapp E Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805 [No Abstract] [Full Text] [Related]